Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Chronic Renal Failure

  Free Subscription


Articles published in Am J Nephrol

Retrieve available abstracts of 144 articles:
HTML format
Text format



Single Articles


    May 2018
  1. YANG X, Tong Y, Yan H, Ni Z, et al
    High Intraperitoneal Interleukin-6 Levels Predict Peritonitis in Peritoneal Dialysis Patients: A Prospective Cohort Study.
    Am J Nephrol. 2018;47:317-324.
    PubMed     Text format     Abstract available


  2. KLEINE CE, Soohoo M, Ranasinghe ON, Park C, et al
    Association of Pre-End-Stage Renal Disease Hemoglobin with Early Dialysis Outcomes.
    Am J Nephrol. 2018;47:333-342.
    PubMed     Text format     Abstract available


  3. IWASHITA Y, Ohya M, Yashiro M, Sonou T, et al
    Dietary Changes Involving Bifidobacterium longum and Other Nutrients Delays Chronic Kidney Disease Progression.
    Am J Nephrol. 2018;47:325-332.
    PubMed     Text format     Abstract available


    April 2018
  4. ZOCCALI C, Mallamaci F
    Obestatin, a Ghrelin-Cognate Protein, and Clinical Outcomes in Hemodialysis Patients.
    Am J Nephrol. 2018;47:251-253.
    PubMed     Text format    


  5. BEBERASHVILI I, Katkov A, Sinuani I, Azar A, et al
    Serum Obestatin: A Biomarker of Cardiovascular and All-Cause Mortality in Hemodialysis Patients.
    Am J Nephrol. 2018;47:254-265.
    PubMed     Text format     Abstract available


  6. CHAN CT, Kaysen GA, Beck GJ, Li M, et al
    Changes in Biomarker Profile and Left Ventricular Hypertrophy Regression: Results from the Frequent Hemodialysis Network Trials.
    Am J Nephrol. 2018;47:208-217.
    PubMed     Text format     Abstract available


    March 2018
  7. NORMAND G, Xu X, Panaye M, Jolivot A, et al
    Pregnancy Outcomes in French Hemodialysis Patients.
    Am J Nephrol. 2018;47:219-227.
    PubMed     Text format     Abstract available


  8. TAN J, Mehrotra A, Nadkarni GN, He JC, et al
    Telenephrology: Providing Healthcare to Remotely Located Patients with Chronic Kidney Disease.
    Am J Nephrol. 2018;47:200-207.
    PubMed     Text format     Abstract available


  9. CHEN W, Bushinsky DA
    Addressing Racial Disparity in the Progression of Chronic Kidney Disease: Prescribe More Fruits and Vegetables?
    Am J Nephrol. 2018;47:171-173.
    PubMed     Text format    


  10. CREWS DC, Banerjee T, Wesson DE, Morgenstern H, et al
    Race/Ethnicity, Dietary Acid Load, and Risk of End-Stage Renal Disease among US Adults with Chronic Kidney Disease.
    Am J Nephrol. 2018;47:174-181.
    PubMed     Text format     Abstract available


  11. KALANTAR-ZADEH K, Parameswaran V, Ficociello LH, Anderson L, et al
    Real-World Scenario Improvements in Serum Phosphorus Levels and Pill Burden in Peritoneal Dialysis Patients Treated with Sucroferric Oxyhydroxide.
    Am J Nephrol. 2018;47:153-161.
    PubMed     Text format     Abstract available


    February 2018
  12. PATZER RE, Basu M, Smith KD, Plantinga L, et al
    Awareness of the New Kidney Allocation System among United States Dialysis Providers with Low Waitlisting.
    Am J Nephrol. 2018;47:115-119.
    PubMed     Text format     Abstract available


  13. KIM JK, Song YR, Lee HS, Kim HJ, et al
    Repeated Bioimpedance Measurements Predict Prognosis of Peritoneal Dialysis Patients.
    Am J Nephrol. 2018;47:120-129.
    PubMed     Text format     Abstract available


  14. WISH JB, Aronoff GR, Bacon BR, Brugnara C, et al
    Positive Iron Balance in Chronic Kidney Disease: How Much is Too Much and How to Tell?
    Am J Nephrol. 2018;47:72-83.
    PubMed     Text format     Abstract available


  15. SINGH M, Raghavan D, Williams JS, Martin BC, et al
    Prevalence of Chronic Kidney Disease, Thrombotic Cardiovascular Events, and Use of Oral P2Y12 Inhibitors among Veterans.
    Am J Nephrol. 2018;47:67-71.
    PubMed     Text format     Abstract available


    January 2018
  16. SUMIDA K, Yamamoto S, Akizawa T, Fukuhara S, et al
    Body Mass Index Change and Hospitalization Risk in Elderly Hemodialysis Patients: Results from Japanese Dialysis Outcomes and Practice Patterns Study.
    Am J Nephrol. 2018;47:48-56.
    PubMed     Text format     Abstract available


  17. CHIN MP, Bakris GL, Block GA, Chertow GM, et al
    Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study.
    Am J Nephrol. 2018;47:40-47.
    PubMed     Text format     Abstract available


  18. TRIEBSWETTER S, Gutjahr-Lengsfeld LJ, Schmidt KR, Drechsler C, et al
    Long-Term Survivor Characteristics in Hemodialysis Patients with Type 2 Diabetes.
    Am J Nephrol. 2018;47:30-39.
    PubMed     Text format     Abstract available


    December 2017
  19. DIVANI M, Georgianos PI, Didangelos T, Iliadis F, et al
    Comparison of Glycemic Markers in Chronic Hemodialysis Using Continuous Glucose Monitoring.
    Am J Nephrol. 2017;47:21-29.
    PubMed     Text format     Abstract available


  20. MOLITCH ME
    Glycemic Control Assessment in the Dialysis Patient: Is Glycated Albumin the Answer?
    Am J Nephrol. 2017;47:18-20.
    PubMed     Text format    


  21. JONES D, You Z, Kendrick JB
    Racial/Ethnic Differences in Barriers to Kidney Transplant Evaluation among Hemodialysis Patients.
    Am J Nephrol. 2017;47:1-7.
    PubMed     Text format     Abstract available


  22. MC CAUSLAND FR, Claggett B, Pfeffer MA, Burdmann EA, et al
    Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial.
    Am J Nephrol. 2017;46:488-497.
    PubMed     Text format     Abstract available


    November 2017
  23. KIDO R, Akizawa T, Fukagawa M, Onishi Y, et al
    Interactive Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers or Their Combination on Survival of Hemodialysis Patients.
    Am J Nephrol. 2017;46:439-447.
    PubMed     Text format     Abstract available


  24. SUMIDA K, Diskin CD, Molnar MZ, Potukuchi PK, et al
    Pre-End-Stage Renal Disease Hemoglobin Variability Predicts Post-End-Stage Renal Disease Mortality in Patients Transitioning to Dialysis.
    Am J Nephrol. 2017;46:397-407.
    PubMed     Text format     Abstract available


  25. CATABAY C, Obi Y, Streja E, Soohoo M, et al
    Lymphocyte Cell Ratios and Mortality among Incident Hemodialysis Patients.
    Am J Nephrol. 2017;46:408-416.
    PubMed     Text format     Abstract available


  26. MALHOTRA R, Tao X, Wang Y, Chen Y, et al
    Performance of the Surprise Question Compared to Prediction Models in Hemodialysis Patients: A Prospective Study.
    Am J Nephrol. 2017;46:390-396.
    PubMed     Text format     Abstract available


  27. TOMINAGA N, Kida K, Inomata T, Sato N, et al
    Effects of Tolvaptan Addition to Furosemide in Normo- and Hyponatremia Patients with Heart Failure and Chronic Kidney Disease Stages G3b-5: A Subanalysis of the K-STAR Study.
    Am J Nephrol. 2017;46:417-426.
    PubMed     Text format     Abstract available


    October 2017
  28. WEIR MR, Pergola PE, Agarwal RL, Fink JC, et al
    A Comparison of the Safety and Efficacy of HX575 (Epoetin Alfa Proposed Biosimilar) with Epoetin Alfa in Patients with End-Stage Renal Disease.
    Am J Nephrol. 2017;46:364-370.
    PubMed     Text format     Abstract available


  29. MADUELL F, Varas J, Ramos R, Martin-Malo A, et al
    Hemodiafiltration Reduces All-Cause and Cardiovascular Mortality in Incident Hemodialysis Patients: A Propensity-Matched Cohort Study.
    Am J Nephrol. 2017;46:288-297.
    PubMed     Text format     Abstract available


    September 2017
  30. MUREA M, Brown WM, Divers J, Moossavi S, et al
    Vascular Access Placement Order and Outcomes in Hemodialysis Patients: A Longitudinal Study.
    Am J Nephrol. 2017;46:268-275.
    PubMed     Text format     Abstract available


  31. LEONBERG-YOO AK, Rudnick MR
    Tobacco Use: A Chronic Kidney Disease Accelerant.
    Am J Nephrol. 2017;46:257-259.
    PubMed     Text format    


  32. ROEHM B, Simoni J, Pruszynski J, Wesson DE, et al
    Cigarette Smoking Attenuates Kidney Protection by Angiotensin-Converting Enzyme Inhibition in Nondiabetic Chronic Kidney Disease.
    Am J Nephrol. 2017;46:260-267.
    PubMed     Text format     Abstract available


  33. LIN MC, Streja E, Soohoo M, Hanna M, et al
    Warfarin Use and Increased Mortality in End-Stage Renal Disease.
    Am J Nephrol. 2017;46:249-256.
    PubMed     Text format     Abstract available


  34. BAIARDI S, Mondini S, Baldi Antognini A, Santoro A, et al
    Survival of Dialysis Patients with Restless Legs Syndrome: A 15-Year Follow-Up Study.
    Am J Nephrol. 2017;46:224-230.
    PubMed     Text format     Abstract available


  35. COLLINS AJ, Pitt B, Reaven N, Funk S, et al
    Association of Serum Potassium with All-Cause Mortality in Patients with and without Heart Failure, Chronic Kidney Disease, and/or Diabetes.
    Am J Nephrol. 2017;46:213-221.
    PubMed     Text format     Abstract available


  36. YU J, Ravel VA, You AS, Streja E, et al
    Association between Testosterone and Mortality Risk among U.S. Males Receiving Dialysis.
    Am J Nephrol. 2017;46:195-203.
    PubMed     Text format     Abstract available


    August 2017
  37. NARA M, Komatsuda A, Numakura K, Saito M, et al
    Quantification of Interstitial Fibrosis in Renal Allografts and Clinical Correlates of Long-Term Graft Function.
    Am J Nephrol. 2017;46:187-194.
    PubMed     Text format     Abstract available


  38. HARDING K, Mersha TB, Webb FA, Vassalotti JA, et al
    Current State and Future Trends to Optimize the Care of African Americans with End-Stage Renal Disease.
    Am J Nephrol. 2017;46:156-164.
    PubMed     Text format     Abstract available


  39. HARDING K, Mersha TB, Vassalotti JA, Webb FA, et al
    Current State and Future Trends to Optimize the Care of Chronic Kidney Disease in African Americans.
    Am J Nephrol. 2017;46:176-186.
    PubMed     Text format     Abstract available


  40. HARDING K, Mersha TB, Pham PT, Waterman AD, et al
    Health Disparities in Kidney Transplantation for African Americans.
    Am J Nephrol. 2017;46:165-175.
    PubMed     Text format     Abstract available


    July 2017
  41. RIBEIRO SC, Figueiredo AE, Barretti P, Pecoits-Filho R, et al
    Impact of Renin-Angiotensin Aldosterone System Inhibition on Serum Potassium Levels among Peritoneal Dialysis Patients.
    Am J Nephrol. 2017;46:150-155.
    PubMed     Text format     Abstract available


  42. HAMDI T, Palmer BF
    Review of Extracorporeal Membrane Oxygenation and Dialysis-Based Liver Support Devices for the Use of Nephrologists.
    Am J Nephrol. 2017;46:139-149.
    PubMed     Text format     Abstract available


  43. BRAR A, Mallappallil M, Stefanov DG, Kau D, et al
    Dialysis in the Elderly and Impact of Institutionalization in the United States Renal Data System.
    Am J Nephrol. 2017;46:114-119.
    PubMed     Text format     Abstract available


  44. KIM T, Streja E, Soohoo M, Rhee CM, et al
    Serum Ferritin Variations and Mortality in Incident Hemodialysis Patients.
    Am J Nephrol. 2017;46:120-130.
    PubMed     Text format     Abstract available


  45. ABE M, Hamano T, Wada A, Nakai S, et al
    High-Performance Membrane Dialyzers and Mortality in Hemodialysis Patients: A 2-Year Cohort Study from the Annual Survey of the Japanese Renal Data Registry.
    Am J Nephrol. 2017;46:82-92.
    PubMed     Text format     Abstract available


  46. AFSHINNIA F, Zeng L, Byun J, Gadegbeku CA, et al
    Myeloperoxidase Levels and Its Product 3-Chlorotyrosine Predict Chronic Kidney Disease Severity and Associated Coronary Artery Disease.
    Am J Nephrol. 2017;46:73-81.
    PubMed     Text format     Abstract available


    June 2017
  47. LIU W, Wang L, Wei Y, Li X, et al
    Interaction of Soluble CXC Ligand 16 and Cardiac Injury Markers in Hemodialysis Patients.
    Am J Nephrol. 2017;46:64-70.
    PubMed     Text format     Abstract available


  48. FERNANDES A, Ribera-Sanchez R, Rodriguez-Carmona A, Lopez-Iglesias A, et al
    Peritoneal Water Transport Characteristics of Diabetic Patients Undergoing Peritoneal Dialysis: A Longitudinal Study.
    Am J Nephrol. 2017;46:47-54.
    PubMed     Text format     Abstract available


  49. AVILA M, Mora C, Prado MDC, Zavala M, et al
    Osteoprotegerin Is the Strongest Predictor for Progression of Arterial Calcification in Peritoneal Dialysis Patients.
    Am J Nephrol. 2017;46:39-46.
    PubMed     Text format     Abstract available


  50. LENHARD MJ, Maser RE
    Vascular Calcification and Osteoprotegrin in Chronic Kidney Disease.
    Am J Nephrol. 2017;46:37-38.
    PubMed     Text format    


  51. HASEGAWA T, Zhao J, Fuller DS, Bieber B, et al
    Erythropoietin Hyporesponsiveness in Dialysis Patients: Possible Role of Statins.
    Am J Nephrol. 2017;46:11-17.
    PubMed     Text format     Abstract available


  52. UDO A, Goodlad C, Davenport A
    Impact of Diabetes on Extracellular Volume Status in Patients Initiating Peritoneal Dialysis.
    Am J Nephrol. 2017;46:18-25.
    PubMed     Text format     Abstract available


    May 2017
  53. HUSSEIN WF, Arramreddy R, Sun SJ, Reiterman M, et al
    Higher Ultrafiltration Rate Is Associated with Longer Dialysis Recovery Time in Patients Undergoing Conventional Hemodialysis.
    Am J Nephrol. 2017;46:3-10.
    PubMed     Text format     Abstract available


  54. PLANTINGA LC, Jaar BG
    On the Right Track: Implementing Interventions to Reduce Readmissions in Dialysis Patients.
    Am J Nephrol. 2017;45:549-551.
    PubMed     Text format    


  55. WANG C, Fu X, Yang Y, Deng J, et al
    A Comparison between Intermittent Peritoneal Dialysis and Automatic Peritoneal Dialysis on Urgent Peritoneal Dialysis.
    Am J Nephrol. 2017;45:540-548.
    PubMed     Text format     Abstract available


  56. WINGARD RL, McDougall K, Axley B, Howard A, et al
    Right TraC Post-Hospitalization Care Transitions Program to Reduce Readmissions for Hemodialysis Patients.
    Am J Nephrol. 2017;45:532-539.
    PubMed     Text format     Abstract available


  57. KIM T, Rhee CM, Streja E, Soohoo M, et al
    Racial and Ethnic Differences in Mortality Associated with Serum Potassium in a Large Hemodialysis Cohort.
    Am J Nephrol. 2017;45:509-521.
    PubMed     Text format     Abstract available


  58. LIU YT, Hung TY, Lee YK, Huang MY, et al
    Association between Chronic Kidney Disease and Risk of Cataract: A Nationwide Retrospective Cohort Study.
    Am J Nephrol. 2017;45:524-531.
    PubMed     Text format     Abstract available


  59. MACK HG, Savige J
    Chronic Kidney Disease and Cataract: Seeing the Light.
    Am J Nephrol. 2017;45:522-523.
    PubMed     Text format    


  60. RAIMANN JG, Barth C, Usvyat LA, Preciado P, et al
    Dialysis Access as an Area of Improvement in Elderly Incident Hemodialysis Patients: Results from a Cohort Study from the International Monitoring Dialysis Outcomes Initiative.
    Am J Nephrol. 2017;45:486-496.
    PubMed     Text format     Abstract available


  61. FERREIRA A, Felipe C, Cristelli M, Viana L, et al
    Donor-Specific Anti-Human Leukocyte Antigens Antibodies, Acute Rejection, Renal Function, and Histology in Kidney Transplant Recipients Receiving Tacrolimus and Everolimus.
    Am J Nephrol. 2017;45:497-508.
    PubMed     Text format     Abstract available


  62. NEE R, Fisher E, Yuan CM, Agodoa LY, et al
    Pre-End-Stage Renal Disease Care and Early Survival among Incident Dialysis Patients in the US Military Health System.
    Am J Nephrol. 2017;45:464-472.
    PubMed     Text format     Abstract available


  63. YEE J, Campbell RC
    The Interdisciplinary Chronic Kidney Disease Clinic: End of the Beginning, Not Beginning of the End.
    Am J Nephrol. 2017;45:461-463.
    PubMed     Text format    


  64. ALSHAHAWEY M, Shahin SM, Elsaid TW, Sabri NA, et al
    Effect of Febuxostat on the Endothelial Dysfunction in Hemodialysis Patients: A Randomized, Placebo-Controlled, Double-Blinded Study.
    Am J Nephrol. 2017;45:452-459.
    PubMed     Text format     Abstract available


    April 2017
  65. BHANDARI SK, Liu IA, Kujubu DA, Huynh T, et al
    Use of Phosphorus Binders among Non-Dialysis Chronic Kidney Disease Patients and Mortality Outcomes.
    Am J Nephrol. 2017;45:431-441.
    PubMed     Text format     Abstract available


  66. FLYTHE JE, Hilbert J, Kshirsagar AV, Gilet CA, et al
    Psychosocial Factors and 30-Day Hospital Readmission among Individuals Receiving Maintenance Dialysis: A Prospective Study.
    Am J Nephrol. 2017;45:400-408.
    PubMed     Text format     Abstract available


    March 2017
  67. MARTIN ER, Smith MT, Maroni BJ, Zuraw QC, et al
    Clinical Trial of Vadadustat in Patients with Anemia Secondary to Stage 3 or 4 Chronic Kidney Disease.
    Am J Nephrol. 2017;45:380-388.
    PubMed     Text format     Abstract available


  68. HAMMES M
    When Is the Right Time for Arteriovenous Fistula Placement in Patients with End-Stage Renal Disease?
    Am J Nephrol. 2017;45:353-355.
    PubMed     Text format    


  69. MIYAMOTO M, Kurita N, Suemitsu K, Murakami M, et al
    Fistula and Survival Outcomes after Fistula Creation among Predialysis Chronic Kidney Disease Stage 5 Patients.
    Am J Nephrol. 2017;45:356-364.
    PubMed     Text format     Abstract available


  70. YI C, Guo Q, Lin J, Li J, et al
    Patient-Doctor Contact Interval and Clinical Outcomes in Continuous Ambulatory Peritoneal Dialysis Patients.
    Am J Nephrol. 2017;45:346-352.
    PubMed     Text format     Abstract available


  71. ILORI TO, Wang X, Huang M, Gutierrez OM, et al
    Oxidative Balance Score and the Risk of End-Stage Renal Disease and Cardiovascular Disease.
    Am J Nephrol. 2017;45:338-345.
    PubMed     Text format     Abstract available


    February 2017
  72. BARAGETTI I, El Essawy B, Fiorina P
    Targeting Immunity in End-Stage Renal Disease.
    Am J Nephrol. 2017;45:310-319.
    PubMed     Text format     Abstract available


  73. FAN Q, Yan Y, Gu L, He L, et al
    Prognostic Value of the Delivery Dialysis Dose on Twice-Weekly Hemodialysis Patients.
    Am J Nephrol. 2017;45:273-282.
    PubMed     Text format     Abstract available


  74. LANGSFORD D, Tang M, Cheikh Hassan HI, Djurdjev O, et al
    The Association between Biomarker Profiles, Etiology of Chronic Kidney Disease, and Mortality.
    Am J Nephrol. 2017;45:226-234.
    PubMed     Text format     Abstract available


    January 2017
  75. WONG LL, Kalantar-Zadeh K, Page V, Hayashida G, et al
    Insights from Screening a Racially and Ethnically Diverse Population for Chronic Kidney Disease.
    Am J Nephrol. 2017;45:200-208.
    PubMed     Text format     Abstract available


  76. LOCATELLI F, Fishbane S, Block GA, Macdougall IC, et al
    Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients.
    Am J Nephrol. 2017;45:187-199.
    PubMed     Text format     Abstract available


  77. BRAR A, Markell M, Stefanov DG, Timpo E, et al
    Mortality after Renal Allograft Failure and Return to Dialysis.
    Am J Nephrol. 2017;45:180-186.
    PubMed     Text format     Abstract available


  78. WOLFGRAM DF, Garcia K, Evans G, Zamanian S, et al
    Association of Albuminuria and Estimated Glomerular Filtration Rate with Functional Performance Measures in Older Adults with Chronic Kidney Disease.
    Am J Nephrol. 2017;45:172-179.
    PubMed     Text format     Abstract available


  79. ABAD S, Vega A, Hernandez E, Merida E, et al
    Universal Sustained Viral Response to the Combination of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with/without Ribavirin in Patients on Hemodialysis Infected with Hepatitis C Virus Genotypes 1 and 4.
    Am J Nephrol. 2017;45:267-272.
    PubMed     Text format     Abstract available


  80. VADUGANATHAN M, Bhatt DL
    Cardiac Troponins in Chronic Kidney Disease: A Marker of Global Cardiovascular Risk.
    Am J Nephrol. 2017;45:301-303.
    PubMed     Text format    


  81. SHARMA K
    Myeloperoxidase Activity and Oxidized Amino Acids as Biomarkers in Chronic Kidney Disease and Coronary Artery Disease.
    Am J Nephrol. 2017;46:71-72.
    PubMed     Text format    


  82. KOVESDY CP, Furth SL, Zoccali C
    Obesity and Kidney Disease: Hidden Consequences of the Epidemic.
    Am J Nephrol. 2017;45:283-291.
    PubMed     Text format     Abstract available


  83. PAYAN SCHOBER F, Jobson MA, Poulton CJ, Singh HK, et al
    Clinical Features and Outcomes of a Racially Diverse Population with Fibrillary Glomerulonephritis.
    Am J Nephrol. 2017;45:248-256.
    PubMed     Text format     Abstract available


  84. COLLISTER D, Sathianathan C, Ryz K, Karpinski M, et al
    ANCA Associated Vasculitis Secondary to Levamisole-Adultered Cocaine with Associated Membranous Nephropathy: A Case Series.
    Am J Nephrol. 2017;45:209-216.
    PubMed     Text format     Abstract available


  85. SARAFIDIS PA
    Online Hemodiafiltration Improves Outcomes in Incident Patients with End-Stage Renal Disease: Another Brick in the Wall?
    Am J Nephrol. 2017;46:285-287.
    PubMed     Text format    


  86. QIU W, Jiang Y, Wu J, Huang H, et al
    Simple Cysts in Donor Kidney Contribute to Reduced Allograft Function.
    Am J Nephrol. 2017;45:82-88.
    PubMed     Text format     Abstract available


  87. HEMPEL JC, Poppelaars F, Gaya da Costa M, Franssen CF, et al
    Distinct in vitro Complement Activation by Various Intravenous Iron Preparations.
    Am J Nephrol. 2017;45:49-59.
    PubMed     Text format     Abstract available


    December 2016
  88. XUE C, Yang B, Zhou C, Dai B, et al
    Fibroblast Growth Factor 23 Predicts All-Cause Mortality in a Dose-Response Fashion in Pre-Dialysis Patients with Chronic Kidney Disease.
    Am J Nephrol. 2016;45:149-159.
    PubMed     Text format     Abstract available


  89. FILLER G, McIntyre C
    Is Fibroblast Growth Factor 23 the New Biomarker for Cardiovascular Mortality in Chronic Kidney Disease Patients?
    Am J Nephrol. 2016;45:146-148.
    PubMed     Text format    


  90. AKIZAWA T, Tsubakihara Y, Nangaku M, Endo Y, et al
    Effects of Daprodustat, a Novel Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor on Anemia Management in Japanese Hemodialysis Subjects.
    Am J Nephrol. 2016;45:127-135.
    PubMed     Text format     Abstract available


  91. REQUE J, Garcia-Prieto A, Linares T, Vega A, et al
    Pulmonary Hypertension Is Associated with Mortality and Cardiovascular Events in Chronic Kidney Disease Patients.
    Am J Nephrol. 2016;45:107-114.
    PubMed     Text format     Abstract available


  92. TABER DJ, Fleming JN, Fominaya CE, Gebregziabher M, et al
    The Impact of Health Care Appointment Non-Adherence on Graft Outcomes in Kidney Transplantation.
    Am J Nephrol. 2016;45:91-98.
    PubMed     Text format     Abstract available


    November 2016
  93. FERREIRA JP, Girerd N, Pannier B, Rossignol P, et al
    High Pulse-Wave Velocity Defines a Very High Cardiovascular Risk Cohort of Dialysis Patients under Age 60.
    Am J Nephrol. 2016;45:72-81.
    PubMed     Text format     Abstract available


  94. ZOCCALI C, Mallamaci F
    Arterial Stiffness as a Cardiovascular Risk Factor in Stage 5D Chronic Kidney Disease Patients: An Age Affair.
    Am J Nephrol. 2016;45:69-71.
    PubMed     Text format    


  95. DE SOUZA VC, Rabilloud M, Cochat P, Wagner MB, et al
    Trajectories and Predictors of Allograft Dysfunction after Renal Transplantation in Children.
    Am J Nephrol. 2016;45:63-68.
    PubMed     Text format     Abstract available


  96. THADHANI R, Zella JB, Knutson DC, Blaser WJ, et al
    2MD (DP001), a Single Agent in the Management of Hemodialysis Patients: A Randomized Trial.
    Am J Nephrol. 2016;45:40-48.
    PubMed     Text format     Abstract available


  97. CHOI Y, Shin J, Park JT, Cho KH, et al
    Disparities in Kidney Transplantation Access among Korean Patients Initiating Dialysis: A Population-Based Cohort Study Using National Health Insurance Data (2003-2013).
    Am J Nephrol. 2016;45:32-39.
    PubMed     Text format     Abstract available


  98. MCCABE KM, Booth SL, Fu X, Ward E, et al
    Vitamin K Metabolism in a Rat Model of Chronic Kidney Disease.
    Am J Nephrol. 2016;45:4-13.
    PubMed     Text format     Abstract available


  99. GALE RC, Kehoe D, Lit YZ, Asch SM, et al
    Effect of a Dialysis Access Coordinator on Preemptive Access Placement among Veterans: A Quality Improvement Initiative.
    Am J Nephrol. 2016;45:14-21.
    PubMed     Text format     Abstract available


  100. FUSARO M, Plebani M, Iervasi G, Gallieni M, et al
    Vitamin K Deficiency in Chronic Kidney Disease: Evidence Is Building Up.
    Am J Nephrol. 2016;45:1-3.
    PubMed     Text format    


  101. SHARMA A, Yabes J, Al Mawed S, Wu C, et al
    Impact of Cognitive Function Change on Mortality in Renal Transplant and End-Stage Renal Disease Patients.
    Am J Nephrol. 2016;44:462-472.
    PubMed     Text format     Abstract available


  102. FOSTER R, Walker S, Brar R, Hiebert B, et al
    Cognitive Impairment in Advanced Chronic Kidney Disease: The Canadian Frailty Observation and Interventions Trial.
    Am J Nephrol. 2016;44:473-480.
    PubMed     Text format     Abstract available


    October 2016
  103. NOVICK T, Liu Y, Alvanzo A, Zonderman AB, et al
    Lifetime Cocaine and Opiate Use and Chronic Kidney Disease.
    Am J Nephrol. 2016;44:447-453.
    PubMed     Text format     Abstract available


  104. LANOT A, Lobbedez T, Bechade C, Verger C, et al
    Efficacy of Prophylactic Antibiotics at Peritoneal Catheter Insertion on Early Peritonitis: Data from the Catheter Section of the French Language Peritoneal Dialysis Registry.
    Am J Nephrol. 2016;44:419-425.
    PubMed     Text format     Abstract available


  105. CHEN TY, Lin TT, Hsieh MY, Lin L, et al
    Circulating Progenitor Cells Affect Thrombosis of Dialysis Arteriovenous Fistulas.
    Am J Nephrol. 2016;44:428-438.
    PubMed     Text format     Abstract available


  106. BUSHINSKY DA, Rossignol P, Spiegel DM, Benton WW, et al
    Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on Hemodialysis.
    Am J Nephrol. 2016;44:404-410.
    PubMed     Text format     Abstract available


  107. MACLAUGHLIN HL, Macdougall IC, Hall WL, Dew T, et al
    Does Intragastric Balloon Treatment for Obesity in Chronic Kidney Disease Heighten Acute Kidney Injury Risk?
    Am J Nephrol. 2016;44:411-418.
    PubMed     Text format     Abstract available


  108. SAKURA M, Inaba M, Yoda K, Ichii M, et al
    High Coronary Heart Disease Risk in Hemodialysis Patients with Central Sleep Apnea: A Pilot Study.
    Am J Nephrol. 2016;44:388-395.
    PubMed     Text format     Abstract available


  109. CHADE AR, Hall JE
    Role of the Renal Microcirculation in Progression of Chronic Kidney Injury in Obesity.
    Am J Nephrol. 2016;44:354-367.
    PubMed     Text format     Abstract available


  110. SAKHUJA A, Wright RS, Schold JD, McCarthy JT, et al
    National Impact of Maintenance Dialysis or Renal Transplantation on Outcomes Following ST Elevation Myocardial Infarction.
    Am J Nephrol. 2016;44:329-338.
    PubMed     Text format     Abstract available


  111. BOLAD IA
    ST-Segment Elevation Myocardial Elevation in Dialysis and Renal Transplant Patients. How Does It Compare to That in the General Population?
    Am J Nephrol. 2016;44:327-328.
    PubMed     Text format    


    September 2016
  112. SPRAGUE SM, Crawford PW, Melnick JZ, Strugnell SA, et al
    Use of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney Disease.
    Am J Nephrol. 2016;44:316-325.
    PubMed     Text format     Abstract available


  113. SMITH ZG, McNicoll L, Clark TL, Cohen AJ, et al
    Medical Neighborhood Model for the Care of Chronic Kidney Disease Patients.
    Am J Nephrol. 2016;44:308-315.
    PubMed     Text format     Abstract available


  114. TRINH E, Chan CT
    Intensive Home Hemodialysis Results in Regression of Left Ventricular Hypertrophy and Better Clinical Outcomes.
    Am J Nephrol. 2016;44:300-307.
    PubMed     Text format     Abstract available


  115. WALLQUIST C, Mansouri L, Norrback M, Hylander B, et al
    Early Changes in Monocyte Adhesion Molecule Expression and Tumor Necrosis Factor-alpha Levels in Chronic Kidney Disease - A 5-Year Prospective Study.
    Am J Nephrol. 2016;44:268-275.
    PubMed     Text format     Abstract available


  116. GENOVESI S
    Oral Anticoagulation in End-Stage Renal Disease: Is It Time to Absolve Warfarin?
    Am J Nephrol. 2016;44:255-257.
    PubMed     Text format    


  117. BRANCACCIO D, Neri L, Bellocchio F, Barbieri C, et al
    Patients' Characteristics Affect the Survival Benefit of Warfarin Treatment for Hemodialysis Patients with Atrial Fibrillation. A Historical Cohort Study.
    Am J Nephrol. 2016;44:258-267.
    PubMed     Text format     Abstract available


  118. JIANG Y, Shen Z, Zhang J, Xing C, et al
    Parathyroidectomy Increases Heart Rate Variability and Leptin Levels in Patients with Stage 5 Chronic Kidney Disease.
    Am J Nephrol. 2016;44:245-254.
    PubMed     Text format     Abstract available


  119. YUSUF AA, Hu Y, Singh B, Menoyo JA, et al
    Serum Potassium Levels and Mortality in Hemodialysis Patients: A Retrospective Cohort Study.
    Am J Nephrol. 2016;44:179-186.
    PubMed     Text format     Abstract available


    August 2016
  120. SAKAO Y, Sugimoto M, Ichikawa H, Sahara S, et al
    Severity of Gastric Mucosal Atrophy Is the Major Determinant of Plasma Ghrelin Level in Hemodialysis Patients.
    Am J Nephrol. 2016;44:224-233.
    PubMed     Text format     Abstract available


  121. AL DHAYBI O, Bakris G
    New Onset Hypertension Linked to Generic Cyclosporine Substitution in Post-Renal Transplant Patient.
    Am J Nephrol. 2016;44:219-223.
    PubMed     Text format     Abstract available


  122. DIAS C, Moore KT, Murphy J, Ariyawansa J, et al
    Rivaroxaban in Chronic Hemodialysis Patients: Clarification of an Editorial Error.
    Am J Nephrol. 2016;44:169.
    PubMed     Text format    


  123. ROCCO MV, Chapman A, Chertow GM, Cohen D, et al
    Chronic Kidney Disease Classification in Systolic Blood Pressure Intervention Trial: Comparison Using Modification of Diet in Renal Disease and CKD-Epidemiology Collaboration Definitions.
    Am J Nephrol. 2016;44:130-140.
    PubMed     Text format     Abstract available


  124. ALICIC RZ, Short RA, Corbett CL, Neumiller JJ, et al
    Medication Intervention for Chronic Kidney Disease Patients Transitioning from Hospital to Home: Study Design and Baseline Characteristics.
    Am J Nephrol. 2016;44:122-129.
    PubMed     Text format     Abstract available


    July 2016
  125. SPRAGUE SM, Covic AC, Floege J, Ketteler M, et al
    Pharmacodynamic Effects of Sucroferric Oxyhydroxide and Sevelamer Carbonate on Vitamin D Receptor Agonist Bioactivity in Dialysis Patients.
    Am J Nephrol. 2016;44:104-112.
    PubMed     Text format     Abstract available


  126. NORRIS KC, Nicholas SB
    Racial Disparities in End-of-Life Issues in Patients with Chronic Kidney Disease.
    Am J Nephrol. 2016;44:81-83.
    PubMed     Text format    


  127. KIM HJ, Lee H, Kim DK, Oh KH, et al
    Recurrent Vascular Access Dysfunction as a Novel Marker of Cardiovascular Outcome and Mortality in Hemodialysis Patients.
    Am J Nephrol. 2016;44:71-80.
    PubMed     Text format     Abstract available


  128. LEMOINE S, Panaye M, Pelletier C, Bon C, et al
    Cystatin C-Creatinine Based Glomerular Filtration Rate Equation in Obese Chronic Kidney Disease Patients: Impact of Deindexation and Gender.
    Am J Nephrol. 2016;44:63-70.
    PubMed     Text format     Abstract available


  129. LEEHEY DJ, Collins E, Kramer HJ, Cooper C, et al
    Structured Exercise in Obese Diabetic Patients with Chronic Kidney Disease: A Randomized Controlled Trial.
    Am J Nephrol. 2016;44:54-62.
    PubMed     Text format     Abstract available


    June 2016
  130. CHAN D, Cheema BS
    Progressive Resistance Training in End-Stage Renal Disease: Systematic Review.
    Am J Nephrol. 2016;44:32-45.
    PubMed     Text format     Abstract available


  131. JOHANSEN KL
    Resistance Exercise in the Hemodialysis Population - Who Should Do the Heavy Lifting?
    Am J Nephrol. 2016;44:29-31.
    PubMed     Text format    


  132. ENEANYA ND, Wenger JB, Waite K, Crittenden S, et al
    Racial Disparities in End-of-Life Communication and Preferences among Chronic Kidney Disease Patients.
    Am J Nephrol. 2016;44:46-53.
    PubMed     Text format     Abstract available


  133. TASEVSKA I, Enhorning S, Christensson A, Persson M, et al
    Increased Levels of Copeptin, a Surrogate Marker of Arginine Vasopressin, Are Associated with an Increased Risk of Chronic Kidney Disease in a General Population.
    Am J Nephrol. 2016;44:22-28.
    PubMed     Text format     Abstract available


  134. SHIRAZIAN S, Diep R, Jacobson AM, Grant CD, et al
    Awareness of Chronic Kidney Disease and Depressive Symptoms: National Health and Nutrition Examination Surveys 2005-2010.
    Am J Nephrol. 2016;44:1-10.
    PubMed     Text format     Abstract available


    May 2016
  135. VASCO RF, Moyses RM, Zatz R, Elias RM, et al
    Furosemide Increases the Risk of Hyperparathyroidism in Chronic Kidney Disease.
    Am J Nephrol. 2016;43:421-430.
    PubMed     Text format     Abstract available


  136. WESSON DE
    Does an Acid-Milieu in Chronic Kidney Disease Contribute to Its Increased Cardiovascular Mortality?
    Am J Nephrol. 2016;43:408-410.
    PubMed     Text format    


  137. DOBRE M, Roy J, Tao K, Anderson AH, et al
    Serum Bicarbonate and Structural and Functional Cardiac Abnormalities in Chronic Kidney Disease - A Report from the Chronic Renal Insufficiency Cohort Study.
    Am J Nephrol. 2016;43:411-420.
    PubMed     Text format     Abstract available


  138. RHEE EP, Clish CB, Wenger J, Roy J, et al
    Metabolomics of Chronic Kidney Disease Progression: A Case-Control Analysis in the Chronic Renal Insufficiency Cohort Study.
    Am J Nephrol. 2016;43:366-374.
    PubMed     Text format     Abstract available


  139. LEE T, Thamer M, Zhang Q, Zhang Y, et al
    Reduced Cardiovascular Mortality Associated with Early Vascular Access Placement in Elderly Patients with Chronic Kidney Disease.
    Am J Nephrol. 2016;43:334-340.
    PubMed     Text format     Abstract available


  140. CLARK WF, Sontrop JM, Huang SH, Moist L, et al
    Hydration and Chronic Kidney Disease Progression: A Critical Review of the Evidence.
    Am J Nephrol. 2016;43:281-292.
    PubMed     Text format     Abstract available


    April 2016
  141. BROWN JR, Rezaee ME, Hisey WM, Cox KC, et al
    Reduced Mortality Associated with Acute Kidney Injury Requiring Dialysis in the United States.
    Am J Nephrol. 2016;43:261-270.
    PubMed     Text format     Abstract available


    January 2016
  142. SRINIVAS T
    Brain Imaging and Cognition after Kidney Transplantation.
    Am J Nephrol. 2016;43:47-9.
    PubMed     Text format    


    August 2015
  143. RUBIN MF, Weir MR
    Access to Kidney Transplantation: Is There a Potential Conflict of Interest?
    Am J Nephrol. 2015;41:502-503.
    PubMed     Text format    


    July 2015
  144. HUANG E, Bunnapradist S
    Pre-Transplant Weight Loss and Survival after Kidney Transplantation.
    Am J Nephrol. 2015;41:448-455.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Renal Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: